Japan Pharmaceutical Manufacturing Market: By Drug Type (Branded Prescription Drugs, Generic Prescription Drugs, Over-The Counter Drugs (OTC)); Formulation (Tablets, Capsules, Injectables, Sprays, Suspensions, Powder, Other Formulations); Route of Administration (Oral Medicine, Topical Medicine, Parenteral Medicine, Inhalations, Other Routes of Administration); Therapeutic Application (Cardiovascular Disease, Pain, Disease, Cancer, Respiratory Diseases, Neurological Diseases, Orthopedics, Other Therapeutic Application); Manufacturing Facility (In- House Facility and Outsourced facility); Distribution Channel (Retail Channel, Non-retail, and Online Channel)—Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2023–2031
Japan pharmaceutical manufacturing market was valued at US$ 31.74 billion in 2022 and is projected to reach market size of US$ 53.90 billion by 2031 at a CAGR of 6.06% during the forecast period 2023–2031. Read More
We Are Trusted By These Great Companies!
Published On: 31-Aug-2023 | Format: | Report ID: AA0923598